ALC Chart, page-3540

The company has great growth potential, however, we must remain patient with a balanced view as the tender process for new contracts in the healthcare industry can be long, competitive and tedious. We have a proven product, now we just need to scale up the contract size to sure up recurring revenue and continue to have year on year growth. If ALC achieve revenue growth around 33% again this financial year that will be a great result, hopefully we get some indication with the September quarterly result. Investors have shown great support for this company with a substantial increase in share price since the acquisition, particularly since March'19, and depending on investors timelines some will naturally take profits based on their price targets and so on. Currently the share price is pricing in forward growth, given this we should be over the moon with share price progress and where we are today.

I appreciate the market can react irrationally more often than not but we can't compare to another stock growing 6 fold in 3 days. I hope for t a strong December quarter of news flow, following, I would anticipate March quarter 2020 to show strong price appreciation on the back of this.

Anyway first poster long term holder of ALC.

fingers cross for a big push to the end of this calendar year.